Pertuzumab (Perjecta) for HER2-positive metastatic breast cancer.

@article{2012PertuzumabF,
  title={Pertuzumab (Perjecta) for HER2-positive metastatic breast cancer.},
  author={},
  journal={The Medical letter on drugs and therapeutics},
  year={2012},
  volume={54 1395},
  pages={
          59-60
        }
}
  • Published in The Medical letter on drugs and therapeutics 2012

Topics from this paper.

Similar Papers

Loading similar papers…